Fluidigm Corporation (FLDM)
(Delayed Data from NSDQ)
$11.89 USD
-1.80 (-13.15%)
Updated May 3, 2019 04:00 PM ET
After-Market: $11.89 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$11.89 USD
-1.80 (-13.15%)
Updated May 3, 2019 04:00 PM ET
After-Market: $11.89 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
CryoLife (CRY) Earnings Beat Estimates, Revenues Lag in Q4
by Zacks Equity Research
CryoLife, Inc. (CRY) posted fourth-quarter 2016 adjusted earnings per share of 12 cents, beating the Zacks Consensus Estimate of 8 cents.
Express Scripts (ESRX) Earnings Top, Revenues Lag in Q4
by Zacks Equity Research
Express Scripts Holding Company (ESRX) posted fourth-quarter 2016 adjusted earnings per share of $1.88, beating the Zacks Consensus Estimate by a penny
Varian (VAR) Eclipse Software Named Category Leader by KLAS
by Zacks Equity Research
Varian Medical Systems (VAR) recently announced that its Eclipse treatment planning software has been named 2017 Category Leader for Oncology Treatment Planning by KLAS.
Becton, Dickinson Launches BD Resolve Early Access Program
by Zacks Equity Research
Leading global medical technology company, Becton, Dickinson and Company (BDX), popularly known as BD, recently announced an early access program for the BD Resolve Single-Cell Gene Expression platform.
Cerner (CERN) Q4 Earnings Meet, Revenues Miss Estimates
by Zacks Equity Research
Cerner Corp(CERN) reported adjusted fourth-quarter 2016 earnings of 57 cents per share, in line with the Zacks Consensus Estimate.
Fluidigm: Q4 Preliminary Results Fail to Cheer Investors
by Zacks Equity Research
The market is not really happy with South San Francisco, CA-based Fluidigm Corporation's (FLDM) preliminary results for the fourth quarter and full-year 2016.
Fluidigm Unveils High-Throughput Integrated Fluidic Circuit
by Zacks Equity Research
Fluidigm Corporation (FLDM), a leading player in the analysis of single cells and industrial application of genomics, recently unveiled a new high-throughput integrated fluidic circuit (HT IFC) to separate single cells during mRNA sequencing analysis.